Blueprint Medicines Corporation (BPMC) has 20 known insider and institutional holders on record. The largest holder is Haviland Kate with 165,929 shares. Other notable holders include Albers Jeffrey W. and Borisy Alexis.
Over the last 12 months, insiders have made 13 transactions in BPMC stock — 8 buys (valued at $53.49M) and 3 sells (valued at $329.92K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
BPMC Insider Ownership
Top Holder
Haviland Kate
165,929 shares
Buys (12 mo)
8
$53.49M value
Sells (12 mo)
3
$329.92K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Haviland Kate |
Chief Executive Officer |
165,929 |
2025-04-03 |
|
| 2 |
Albers Jeffrey W. |
Director |
150,532 |
2025-06-24 |
|
| 3 |
Borisy Alexis |
Director |
78,062 |
2025-06-24 |
|
| 4 |
Namouni Fouad |
President, R & D |
75,781 |
2025-03-07 |
|
| 5 |
Landsittel Michael |
Chief Financial Officer |
72,924 |
2025-03-07 |
|
| 6 |
Mccain Tracey L |
EVP and Chief Legal Officer |
66,583 |
2025-03-07 |
|
| 7 |
Rossi Christina |
Chief Operating Officer |
64,718 |
2025-05-21 |
|
| 8 |
Carter Percy H. |
Chief Scientific Officer |
54,206 |
2025-06-05 |
|
| 9 |
Durso-bumpus Debra |
Chief People Officer |
49,606 |
2025-03-07 |
|
| 10 |
Lee Philina |
Chief Commercial Officer |
41,996 |
2025-03-07 |
|
| 11 |
Hewes L. Becker |
Chief Medical Officer |
35,651 |
2025-03-07 |
|
| 12 |
Murray Christopher K. |
Chief Technical Operations |
33,853 |
2024-03-11 |
|
| 13 |
Goldberg Mark Alan |
Director |
22,156 |
2025-06-24 |
|
| 14 |
Seely Lynn |
Director |
17,156 |
2025-06-24 |
|
| 15 |
Dorsch Marion |
Chief Scientific Officer |
15,250 |
2021-02-24 |
|
| 16 |
Beckman Daniella |
Director |
14,744 |
2025-06-24 |
|
| 17 |
Tsai John |
Director |
12,644 |
2025-06-24 |
|
| 18 |
Dable Habib J |
Director |
12,644 |
2025-06-24 |
|
| 19 |
Boral Anthony L. |
Chief Medical Officer |
7,483 |
2020-12-16 |
|
| 20 |
Coats Lonnel |
Director |
6,144 |
2025-06-24 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-06-18 |
Tsai John |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Dable Habib J |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Albers Jeffrey W. |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Coats Lonnel |
Director |
RSU Award |
3,902 |
$12,812.00 |
$49.99M |
| 2025-06-18 |
Goldberg Mark Alan |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Beckman Daniella |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Seely Lynn |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-18 |
Borisy Alexis |
Director |
RSU Award |
3,902 |
$128.12 |
$499.92K |
| 2025-06-03 |
Carter Percy H. |
Chief Scientific Officer |
Informative Sell |
2,418 |
$127.88 |
$309.21K |
| 2025-05-27 |
Albers Jeffrey W. |
Director |
Option Exercise (Sell) |
5,000 |
$36.05 |
$180.25K |
| 2025-05-19 |
Rossi Christina |
Chief Operating Officer |
Informative Sell |
57 |
$101.72 |
$5.8K |
| 2025-05-05 |
Hurley Ariel |
Principal Accounting Officer |
Option Exercise (Sell) |
2,752 |
$54.13 |
$148.97K |
| 2025-05-05 |
Rossi Christina |
Chief Operating Officer |
Informative Sell |
144 |
$103.56 |
$14.91K |
